91 related articles for article (PubMed ID: 11069255)
1. Bioactive cytidine deaminase, an inhibitor of granulocyte-macrophage colony-forming cells, is massively released in fulminant meningococcal sepsis.
Bøyum A; Tennfjord VA; Gran C; Løvhaug D; Oktedalen O; Brandtzaeg P
J Infect Dis; 2000 Dec; 182(6):1784-7. PubMed ID: 11069255
[TBL] [Abstract][Full Text] [Related]
2. Identification of cytidine deaminase as inhibitor of granulocyte-macrophage colony formation.
Bøyum A; Løvhaug D; Seeberg E; Nordlie EM
Exp Hematol; 1994 Feb; 22(2):208-14. PubMed ID: 7507861
[TBL] [Abstract][Full Text] [Related]
3. Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock.
Bjerre A; Brusletto B; Høiby EA; Kierulf P; Brandtzaeg P
Crit Care Med; 2004 Feb; 32(2):433-8. PubMed ID: 14758160
[TBL] [Abstract][Full Text] [Related]
4. Does granulocyte colony-stimulating factor ameliorate the proinflammatory response in human meningococcal septic shock?
Rojahn A; Brusletto B; Øvstebø R; Haug KB; Kierulf P; Brandtzaeg P
Crit Care Med; 2008 Sep; 36(9):2583-9. PubMed ID: 18679115
[TBL] [Abstract][Full Text] [Related]
5. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.
Bjerre A; Brusletto B; Øvstebø R; Joø GB; Kierulf P; Brandtzaeg P
J Endotoxin Res; 2003; 9(3):155-63. PubMed ID: 12831456
[TBL] [Abstract][Full Text] [Related]
6. Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia.
Waring PM; Presneill J; Maher DW; Layton JE; Cebon J; Waring LJ; Metcalf D
Clin Exp Immunol; 1995 Dec; 102(3):501-6. PubMed ID: 8536364
[TBL] [Abstract][Full Text] [Related]
7. Fulminant meningococcal septicemia: dissociation between plasma thrombopoietin levels and platelet counts.
Bjerre A; Ovstebø R; Kierulf P; Halvorsen S; Brandtzaeg P
Clin Infect Dis; 2000 Apr; 30(4):643-7. PubMed ID: 10770723
[TBL] [Abstract][Full Text] [Related]
8. Pentraxin 3 and C-reactive protein in severe meningococcal disease.
Sprong T; Peri G; Neeleman C; Mantovani A; Signorini S; van der Meer JW; van Deuren M
Shock; 2009 Jan; 31(1):28-32. PubMed ID: 18650775
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M
Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of granulocyte-macrophage colony-forming cells by human cytidine deaminase requires the catalytic function of the protein.
Gran C; Bøyum A; Johansen RF; Løvhaug D; Seeberg EC
Blood; 1998 Jun; 91(11):4127-35. PubMed ID: 9596658
[TBL] [Abstract][Full Text] [Related]
11. Adrenocorticotropic hormone and cortisol levels in relation to inflammatory response and disease severity in children with meningococcal disease.
van Woensel JB; Biezeveld MH; Alders AM; Eerenberg AJ; Endert E; Hack EC; von Rosenstiel IA; Kuijpers TW
J Infect Dis; 2001 Dec; 184(12):1532-7. PubMed ID: 11740728
[TBL] [Abstract][Full Text] [Related]
12. Peaks of endogenous G-CSF serum concentrations are followed by an increase in respiratory burst activity of granulocytes in patients with septic shock.
Barth E; Fischer G; Schneider EM; Moldawer LL; Georgieff M; Weiss M
Cytokine; 2002 Mar; 17(5):275-84. PubMed ID: 12027409
[TBL] [Abstract][Full Text] [Related]
13. Treatment of fulminant meningococcemia with recombinant tissue plasminogen activator.
Zenz W; Muntean W; Zobel G; Grubbauer HM; Gallistl S
Thromb Haemost; 1995 Aug; 74(2):802-3. PubMed ID: 8585030
[No Abstract] [Full Text] [Related]
14. Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro.
Kirch HC; Schröder J; Hoppe H; Esche H; Seeber S; Schütte J
Exp Hematol; 1998 May; 26(5):421-5. PubMed ID: 9590659
[TBL] [Abstract][Full Text] [Related]
15. CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity.
Vermont CL; Hazelzet JA; de Kleijn ED; van den Dobbelsteen GP; de Groot R
Crit Care; 2006 Feb; 10(1):R33. PubMed ID: 16507164
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor pathway inhibitor (TFPI) levels in the plasma and urine of children with meningococcal disease.
Eling M; Stephens AC; Oragui EE; Rivers RP; Levin M
Thromb Haemost; 2001 Feb; 85(2):240-4. PubMed ID: 11246540
[TBL] [Abstract][Full Text] [Related]
17. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis.
Emonts M; Sweep FC; Grebenchtchikov N; Geurts-Moespot A; Knaup M; Chanson AL; Erard V; Renner P; Hermans PW; Hazelzet JA; Calandra T
Clin Infect Dis; 2007 May; 44(10):1321-8. PubMed ID: 17443469
[TBL] [Abstract][Full Text] [Related]
18. [Indices of oxidative-reductive processes in meningococcal infection].
Vengerov IuIa; Arkhipov AS
Sov Med; 1979 May; (5):58-61. PubMed ID: 451724
[No Abstract] [Full Text] [Related]
19. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
Lee J; Kim Y; Lim J; Kim M; Han K
Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
[TBL] [Abstract][Full Text] [Related]
20. [Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].
Llinares Tello F; Hernández Prats C; Burgos San José A; Bosacoma Ros N; Alcalá Minagorre P; López Rodríguez F; Reig Sáenz R; Marco Vera P; Ordovás Baines JP
Farm Hosp; 2004; 28(2):130-6. PubMed ID: 15101805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
